The management of suspected bile duct stones (BDS) in patients undergoing laparoscopic cholecystectomy (LC) remains controversial and depends on local technical expertise. This 12-year study evaluates the effect of more stringent selection criteria for pre-operative ERCP implemented over the last 6 years of the study period.
METHODS: All patients undergoing LC from 1992-2003 were evaluated for the utilization and findings of ERCP. The indications for pre-LC ERCP from 1992-1997 were one or more of the following: hyperbilirubinemia, bile duct dilation, and elevated liver-associated enzymes. The criteria for pre-LC ERCP from 1998-2003 were that the patient must have at least two of the following:hyperbilirubinemia, ductal dilation, and persistently abnormal or rising liver-associated enzymes. RESULTS:Of 7583 patients who underwent LC 1,319 patients (17%) had pre-LC ERCP and 347 (5%) had post-LC ERCP. BDS were extracted from 763 patients (10%), in 626 (82%) at pre-LC ERCP and in 137 (18%) at post-LC ERCP. ERCP findings are summarized below:Table 1
1st Period | 2nd Period | Overall Series | |
Pre-LC ERCP | 1992-1997 | 1998-2003 | 1992-2003 |
# patients | 807/2810 (29%) | 512/4773 (11%) | 1319/7583 (17%) |
BDS found | 348/807 (43%) | 278/512 (54%) | 626/1319 (47%) |
Table 2
1st Period | 2nd Period | |
Post-LC ERCP | 1992-1997 | 1998-2003 |
# patients | 141/2810 (5% of LC) | 206/4773 (4% of LC) |
# BDS | 48/141 (34%) | 89/206 (43%) |
# leak/stricture | 34/141 (24%) | 28/206 (14%) |
# normal | 59/141 (42%) | 89/206 (43%) |